Drugs and drug prices -- The American way to discover drugs -- The drug industry today -- Are drug companies risky? -- How not to lower drug prices -- Squandering R&D resources -- How to lower drug prices -- Our solution in detail

Cover -- Contents -- Acknowledgments -- Introduction: The Price of Modern Development -- Chapter 1: Why Is this Happening? -- Chapter 2: Quantifying the Resource, Environmental, and Social Impact -- Chapter 3: The European Model -- Chapter 4: The American Model -- Chapter 5: Asian Approaches --...

Intro -- Contents -- I. Introduction -- II. Market Practice -- III. Modeling a CCL -- IV. Replicating Portfolio -- V. Pricing -- A. Method 1 -- B. Method 2 -- VI. Hedging Issues -- VII. Concluding Remarks -- References.

Intro -- Contents -- I. INTRODUCTION -- II. VARIANCE ANALYSIS OF THE PESO-DOLLAR REAL EXCHANGE RATE -- III. SUDDEN STOPS AND NONTRADABLES-DRIVEN REAL EXCHANGE RATE VOLATILITY -- IV. CONCLUSIONS -- REFERENCES.